Global Statistics

All countries
164,288,182
Confirmed
Updated on May 18, 2021 3:02 am
All countries
144,238,856
Recovered
Updated on May 18, 2021 3:02 am
All countries
3,404,897
Deaths
Updated on May 18, 2021 3:02 am
Tuesday, May 18, 2021

Global Statistics

All countries
164,288,182
Confirmed
Updated on May 18, 2021 3:02 am
All countries
144,238,856
Recovered
Updated on May 18, 2021 3:02 am
All countries
3,404,897
Deaths
Updated on May 18, 2021 3:02 am
Molderizer and Safe Shield

Firm to Expand Norwood Plant to Boost Production – NBC Boston

Exclusive-India unlikely to resume sizable COVID-19 vaccine exports until October -sources

NEW DELHI (Reuters) - India is unlikely to resume major exports of COVID-19 vaccines until at least October as it diverts shots for...

Rwanda receives coronavirus supplies from Dubai ruling family

Rwanda has received over 300000 pieces of Personal Protective Equipment (PPE) and medical equipment from the United Arab Emirates (UAE) ruling family. source

How the Pfizer-BioNTech COVID-19 vaccine was developed

--- 60 Minutes, the most successful American television broadcast in history, began its 52nd season in September. Offering hard-hitting investigative reports, ... source

Vodafone Shares Fall After Fiscal Year 2021 Adjusted Earnings Missed Expectations — Update

--Vodafone reported adjusted earnings for fiscal 2021 below consensus forecasts, sending shares lower --The company has been hit by...

Coronavirus update: Latest Covid-19 vaccine and world news

The Delhi government said it has just four days’ worth of Covid-19 vaccines left. ...


Cambridge, Massachusetts-based pharmaceutical firm Moderna will expand its plant in Norwood as the company seeks to increase production of its COVID-19 vaccine at the site by 50%.

The company said in a statement the project will expand the site’s production and lab space from some 300,000 square feet to some 650,000 square feet.
The firm said it expects to ramp up production there in late 2021 or early 2022.

“Our manufacturing facility has been core to our long-term strategy and has enabled us to provide the scale and flexibility to support the development of our mRNA medicines and vaccines including our COVID-19 vaccine,” CEO Stéphane Bancel said.

Moderna released findings on Tuesday from its phase three trial which showed that its coronavirus vaccine is 90% effective at preventing infections and more than 95% effective against severe disease up to six months after the second dose.

“We believe that this investment and expansion at our technology center will allow us to continue to optimize our mRNA products as we explore new pharmaceutical delivery forms such as prefilled syringes and lyophilized products.”
Bancel said the firm is committed to “minimizing our environmental footprint” as it expands.

The expansion will also allow the company to increase production of preclinical for research and development, the statement said.

Moderna’s COVID-19 vaccine is one of three being administered in the U.S. along with those developed by Pfizer and Johnson & Johnson.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Exclusive-India unlikely to resume sizable COVID-19 vaccine exports until October -sources

NEW DELHI (Reuters) - India is unlikely to resume major exports of COVID-19 vaccines until at least October as it diverts shots for...

Rwanda receives coronavirus supplies from Dubai ruling family

Rwanda has received over 300000 pieces of Personal Protective Equipment (PPE) and medical equipment from the United Arab Emirates (UAE) ruling family. source

How the Pfizer-BioNTech COVID-19 vaccine was developed

--- 60 Minutes, the most successful American television broadcast in history, began its 52nd season in September. Offering hard-hitting investigative reports, ... source

Related Articles

Exclusive-India unlikely to resume sizable COVID-19 vaccine exports until October -sources

NEW DELHI (Reuters) - India is unlikely to resume major exports of COVID-19 vaccines until at least October as it diverts shots for...

Rwanda receives coronavirus supplies from Dubai ruling family

Rwanda has received over 300000 pieces of Personal Protective Equipment (PPE) and medical equipment from the United Arab Emirates (UAE) ruling family. source

How the Pfizer-BioNTech COVID-19 vaccine was developed

--- 60 Minutes, the most successful American television broadcast in history, began its 52nd season in September. Offering hard-hitting investigative reports, ... source